From Viking Therapeutics Set to Make Nasdaq Debut Following IPO:

Nasdaq Green 1486x986 (Used with Permission Copyright 2014 NASDAQ OMX Group)

Nasdaq Green 1486×986 (Used with Permission Copyright 2014 NASDAQ OMX Group)—

Stock image of Nasdaq

Underwriters and Partners

Xconomy Insight

Sponsored · Whitepaper
Potency Assay Development for Cell and Gene Therapy Products
Create well-controlled, biologically relevant test systems and validate them to support FDA approvals
Absorption Systems

Sponsored · Whitepaper
The Importance of Early Key Opinion Leader Outreach in the Biologics & Biosimilars Marketplace
Acknowledging various stakeholder networks and regulatory environment variances is essential to uncover the right decision-makers in support of biologics or biosimilars
IBM Watson

From Our Editors · Podcast
Xcelerating Life Sciences San Diego: The Highlights Podcast
Learn what's fueling San Diego's biotech investment and partnership opportunities

Xconomy on Demand

We offer a number of ways to subscribe for free!